Dexcom Inc. received U.S. FDA clearance for its Smart Basal CGM-integrated basal insulin dosing optimizer. Designed for adults with type 2 diabetes using glargine U-100 long-acting insulin therapy, ...

Agios Pharmaceuticals Inc. reported top-line data from its 52-week Rise Up trial testing oral pyruvate kinase activator mitapivat in sickle cell disease (SCD), which hit statistical significance on ...

At the 2025 annual meeting of the Society for Neuroscience in San Diego this week, Catherine Woolley’s plenary lecture was an ...

Harbour Biomed is stepping up its antibody discovery process by using AI to develop innovative therapeutics. “We have done ...

Success in Japan may further bolster Protara Therapeutics Inc. in its push with TARA-002 in pediatric patients with ...

Tempest Therapeutics Inc. entered definitive agreements approved by its board to acquire certain dual-targeting CAR T ...

In a verbal sparring over who can deliver the lowest drug prices in the U.S., several Senate Democrats are urging President ...

U.S. and European organ-on-a-chip specialty biotechnology companies are driving development of organ-on-a-chip technologies, ...

Med-tech M&A activity cooled in October, with the total disclosed deal value reaching $1.68 billion, a step down from ...

The European Commission posted a series of proposed legislative updates, including the AI Act, which might not come into ...

The limited efficacy of cancer immunotherapy is usually attributed to suboptimal antitumor T-cell generation, as well as ...

Radiopharm Theranostics Ltd. has been granted Bellberry Human Research Ethics Committee (HREC) approval in Australia to ...